Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Nothing in this 10Q that should have initiated the restriction
Reply New Message
Prev Message Back To Forum Threaded View Next Message

milestone,

"I humbly suggest that no prior reports covered a settlement to litigation, and it is this which makes it different."

The PR released back in December disclosed as much about the settlement as the quarterly did. If not, how so... Unless you assume we settled for nothing…?

Bluewing

The Q gave revenue from PDS, the PR did not.

Be well

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply